Abstract:Objective:Alport syndrome(AS)is a hereditary disorder in which mutations are implicated in COL4A5 gene encoding α5 chain of type Ⅳcollagen.This study aimed to analyze the clinical features of Chinese AS patients and to identify deletions and mutations of COL4A5 gene in Chinese AS patients about which little data is available in the literature. Methodology:Fifty unrelated Alport syndrome(AS) patients(32 males and 18 females)were analyzed.At the same time,screening for mutations in all the exons(1 to 51)of the COL4A5 gene was carried out by PCR-SSCP or PCR-direct sequence analysis on genomic DNA from 33 unrelated patients with X-linked AS(22 males and 11 females). Results:Analysis of the clinical data showed 96% of the patients presented with hematuria while 84% with glomerular hematuria confirmed by urinary RBC morphologic examination.Eighty-two percent of patients had proteinuria,of whom 22% with a nephrotic level proteinuria.Hearing impairment was detected in 34% of patients undertaken pourtone audiometry.The hearing impairment was not found parallel with the renal insufficiency.Occular abnormalities were found in 18% of patients examined and were not dependent on the occurring of hearing loss.About 82% of patients belonged to juvenile kindred.There was 32% of the patients without any positive family history.Detection of α5(Ⅳ)chain in epidermal basement membrane(EBM)supported the diagnosis of AS in 94% of the patients who had skin biopsy.PCR-SSCP analysis showed a mobility shift in 5 of the 16 patients and 4 female family members.DNA sequence analysis revealed 3 missense mutations(in exons 17,20 and 26),2 silent mutations(in exon 39 and 46)and 1 C→A substitution(in intron 3).PCR-Southern hybridization analysis proved a AS boy with a large deletion of the paired COL4A5 and COL4A6 genes. Conclusion:Chinese AS patients are characterized clinically with hematuria,heavy proteinuria,and lower rates of both hearing loss and ocular abnormalities.Mutations in Chinese AS patients were predominantly small mutations including a large deletion involving the 5 part of both COL4A5 and COL4A6 genes.

A comparison of phenotypic features in patients of X-linked and autosomal recessive Alport syndrome

Comparison of phenotypic features between patients with X-linked and autosomal recessive Alport syndrome

[Features of Clinical Phenotype and Genotype in Alport Syndrome: a Monocentric Study].

Genotype-phenotype correlations in 17 Chinese patients with autosomal recessive Alport syndrome.

Features of Phenotype and Genotype in Chinese Alport Syndrome Patients

Phenotypic and genotypic features of Alport syndrome in Chinese children

Effect of Heterozygous Pathogenic COL4A3 or COL4A4 Variants on Patients with X-linked Alport Syndrome.

[Clinical and Pathological Study of 47 Cases with Alport Syndrome].

Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane]

Analyzing three pedigrees in X-linked Alport syndrome with the presentation of nephrotic syndrome

Analysis of the Clinical Audiological Characteristics in 92 Chinese Alport Syndrome Cases

Dissecting the genotype-phenotype correlation of <i>COL4A5</i> gene mutation and its response to renin-angiotensin-aldosterone system blockers in Chinese male patients with Alport syndrome

Correlation Between Mrna Expression Level of the Mutant COL4A5 Gene and Phenotypes of XLAS Females.

Genotype-Phenotype Correlations for Pathogenic COL4A3–COL4A5 Variants in X-Linked, Autosomal Recessive, and Autosomal Dominant Alport Syndrome

Prenatal Diagnosis And Genetic Counseling Of A Chinese Alport Syndrome Kindred

Genetic features and kidney morphological changes in women with X-linked Alport syndrome

Identification of a Novel COL4A5 Mutation in the Proband Initially Diagnosed As IgAN from a Chinese Family with X-linked Alport Syndrome.

Genetic diagnosis of Alport syndrome in 16 Chinese families

Spectrum of clinical features and type IV collagen α-chain distribution in Chinese patients with Alport syndrome

[Analysis of Diagnosis and Treatment of Alport Syndrome].

Novel Mutations In Col4a3, Col4a4, And Col4a5 In Chinese Patients With Alport Syndrome